
Amarin PM1 Tablet ER
Marketer
Ernst Pharmacia
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Amarin PM1 Tablet ER
Glycemic control in adults with type 2 diabetes mellitus is aided by the combined-action medication, Amarin PM1 Extended-Release Tablet. This medication, used alongside a balanced diet and regular exercise program, enhances insulin effectiveness, thus reducing elevated blood glucose. Dosage and treatment duration should strictly follow your physician's instructions. Administer this medication with food to mitigate gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is essential. Commonly reported side effects encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, individuals with pre-existing kidney, liver, or cardiac conditions should consult their physician. Pregnant or lactating women should also seek medical advice. Renal function will be assessed by your doctor before initiating therapy. Limit alcohol consumption during treatment to minimize the potential for adverse effects.
Primary Ingredients of Amarin PM1 Tablet ER
No text provided to rephrase.
Uses of Amarin PM1 Tablet ER
Managing type 2 diabetes
Major Benefits of Amarin PM1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Amarin PM1 Extended-Release tablets should be administered with a meal.
Common Side effects of Amarin PM1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Amarin PM1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Amarin PM1 Extended-Release tablets should be administered with a meal.
How Amarin PM1 Tablet ER works:
Amarin PM1 Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ different modes of action to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Amarin PM1 Tablet ER and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Amarin PM1 Extended-Release tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Postpartum administration of Amarin PM1 extended-release tablets may pose a risk to breastfeeding infants. Available human data indicates potential transfer of the medication into breast milk, potentially causing harm to the nursing child.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar levels.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Amarin PM1 Tablet ER, as dose modification may be necessary. Individuals with severe kidney disease should avoid this medication. Close monitoring of kidney function is recommended during treatment with Amarin PM1 Tablet ER; consult your physician for guidance.
LiverCAUTION
Patients with liver impairment should use Amarin PM1 Tablet ER cautiously, potentially requiring dose modification. Consult your physician. Amarin PM1 Tablet ER is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Amarin PM1 Tablet ER :
Should you forget a dose of Amarin PM1 Tablet ER, take it immediately if you remember. But, if your next dose is nearly due, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Amarin PM1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
